In short
Researchers are exploring an innovative imaging technique using hyperpolarized Xenon-129 (129Xe) in Magnetic Resonance Imaging (MRI) to study progressive fibrosing interstitial lung diseases. This non-invasive method aims to identify early signs of pulmonary fibrosis and assess its effects on cardiac function. The study also seeks to evaluate risk factors and therapeutic responses to anti-fibrotic drugs, potentially revolutionizing how we diagnose and monitor these challenging lung conditions.
At a glance
- Study Title
- Hyperpolarized 129-Xenon MRI in Fibrosing Interstitial Lung Disease
- Main Objective
- To investigate non-invasive imaging for identifying early signs of pulmonary fibrosis and cardiac dysfunction in fibrosing interstitial lung disease patients
- Study Drug
- Hyperpolarized Xenon-129 (129Xe) inhalation solution
- Administration Method
- Inhalation
- Dosage Forms
- 400 ml, 500 ml, 650 ml, 800 ml, and 1000 ml
- Primary Endpoints
- MR xenon ventilation and dissolved parameters, pulmonary function tests, HRCT parameters, patient-reported symptoms
- Secondary Endpoints
- Regional perfusion changes, myocardial strain and fibrosis, late contrast enhancement
- Key Inclusion Criteria
- Diagnosed with IPF or fibrotic ILD, prescribed anti-fibrotic treatment, cognitively able to participate
- Key Exclusion Criteria
- MRI contraindications, inability to hold breath for 20 seconds, Xenon allergy, ongoing respiratory infections
What is XENON (129XE)?
XENON (129XE) is a special form of xenon gas used as an imaging agent in medical research. It's not a traditional medication that treats diseases directly, but rather a tool doctors use to get better pictures of what's happening inside your lungs. The technical name for this type of imaging agent is a contrast agent, which helps make certain parts of your body show up more clearly on medical scans.
Medical Conditions XENON (129XE) is Used For
XENON (129XE) is being studied for use in patients with a group of lung diseases called Progressive Fibrosing Interstitial Lung Diseases (ILDs). These are conditions where the lungs become scarred over time, making it harder to breathe. Some examples include:
- Idiopathic Pulmonary Fibrosis (IPF): A type of lung disease where the cause of the scarring is unknown
- Other types of fibrotic ILDs that get worse over time
The goal is to use XENON (129XE) to help doctors better understand and monitor these diseases.
How XENON (129XE) Works
XENON (129XE) is used in a special type of imaging called Magnetic Resonance Imaging (MRI). Here's how it works:
- The xenon gas is made into a special form called "hyperpolarized," which makes it show up very clearly on MRI scans.
- When you breathe in the gas, it travels into your lungs and even dissolves slightly into your blood and tissues.
- The MRI machine can then create detailed images of your lungs, showing how well air is flowing and how the gas is moving into your blood.
This gives doctors a unique view of how your lungs are functioning, which isn't possible with regular MRI or CT scans.
How XENON (129XE) is Administered
XENON (129XE) is given as an inhalation solution, which means you breathe it in. The amount you inhale can vary, but typically ranges from 400 ml to 1000 ml (about 1/2 to 1 liter). You'll be asked to hold your breath for a short time (at least 20 seconds) while the images are taken.
Who Can Use XENON (129XE)?
XENON (129XE) is currently being studied in specific groups of people. You might be eligible if you:
- Have been diagnosed with a progressive fibrosing interstitial lung disease
- Are prescribed anti-fibrotic treatment (medications to slow down lung scarring)
- Can understand and participate in the study
- If you're a woman of childbearing age, you must not be pregnant
Safety Considerations
While XENON (129XE) is generally considered safe, there are some people who shouldn't use it:
- People with certain metal implants or devices (like pacemakers) that aren't safe for MRI
- Those who are claustrophobic (fear of enclosed spaces)
- People who can't hold their breath for at least 20 seconds
- Anyone allergic to xenon
- Those with ongoing respiratory infections
It's important to discuss any health conditions or concerns with your doctor before participating in a study using XENON (129XE).
Research Goals and Potential Benefits
The main goals of research using XENON (129XE) include:
- Finding early signs of pulmonary fibrosis (lung scarring)
- Monitoring how lung diseases progress over time
- Evaluating how well anti-fibrotic treatments are working
- Assessing how lung disease might be affecting heart function
By providing more detailed information about lung function, XENON (129XE) imaging could potentially help doctors:
- Diagnose lung diseases earlier
- Make more informed decisions about treatment
- Better understand how treatments are working
This research is still ongoing, and XENON (129XE) is not yet widely available outside of clinical trials. However, it represents an exciting new tool in the field of lung disease research and treatment.